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Abstract 
The elevated activity of matrix metalloproteinase (MMP)-9 has been responsible for degradation 
of extracellular matrix (ECM) within lung parenchyma leading to emphysema among patients 
suffering from chronic obstructive pulmonary disease (COPD). Prolonged exposure of smoking 
had triggered activation of both MMP-9 and MMP-3. Active MMP-3 might degrade numerous 
kinds of ECM and act as MMP-9 inducer as well. The study aimed to correlate active MMP-3 
towards elevated MMP-9 activity from both gingival crevicular fluid (GCF) and sputum to assess 
breakage of extracellular matrix (ECM) among emphysematous patients. Fifteen 
emphysematous respondents suffering from COPD were recruited to undergo thoroughly 
physical assessment, spirometry, and radiological examination. Then, both GCF and sputum 
were collected for measurement of MMP-3 and MMP-9 activity. Results showed that MMP-3 
activities were correlated positively and significant with elevated MMP-9 activities from both 
GCF and sputum i.e. r = 0.899 (p<0.05) and r = 0.770 (p<0.05) respectively. Smoking 
exposure released many radicals and oxidants generating elevation of MMP-3 activity which 
then influenced repeatedly influx of neutrophils and activation of MMP-9. The role of active 
MMP-3 also involved in either acute inflammatory or broad ECM breakage. Moreover, active 
MMP-9 might lead mainly the degradation of ECM within lung parenchyma. Because of similar 
effect and impact concerning ECM degradation, both active MMP-3 and MMP-9 might 
concurrently cause larger breakage of ECM leading to lung emphysema among COPD patients. 
This study showed that both GCF and sputum would be assigned to evaluate active MMP-3 and 
MMP-9 for assessing ECM degradation among emphysematous patients. 
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Introduction 
Smoking  has been the major risk factor for COPD development  of 20-25% smokers.  The more 
cigarette consumed is linear with the higher risk occurs among smokers1. Smoking also exposes oral 
cavity including  the periodontal  tissues (Pejčić  et al., 2007; Usher AK and Stockley RA, 2013). 
Smoking induces inflammatory mediators leading releasing neutrophils, macrophages, and other 
cytokines from exposed tissues. Within lung, prolonged exposure of smoking might lead the 
morphological changes namely emphysema. The disorders of alveoli, enlargement of terminal bronchi, 
decrease of elastic recoil, and worse lung function are easily found among emphysematous patients 
(Daheshia, 2005; Churg et al., 2012). 
 
Emphysema mostly happens as elastolytic destruction process since Matrix metalloproteinase (MMP)-9 
activity increases and so does MMP-9/TIMP-1 ratio (Churg A et al., 2012; Le Quément et al., 2008). 
Evaluation of both MMP-9 activity and MMP-9/TIMP-1 ratio has been useful to assess the progressivity 
of emphysema among chronic obstructive pulmonary disease (COPD) (Boschetto et al., 2006). Those 
parameters also take place in destructing periodontal tissues (Rai et al., 2010). Some studies still 
engaged MMP-9 activity to assess the recovery of COPD and periodontitis among patients who stop 
smoking after treatment as MMP-9 activity has shown elevated and influenced poor recovery of 
diseases (Louhelainen et al., 2010; Rauten et al., 2011). 
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Regarding MMP-3, it has numerous substrates, as does MMP-9. Moreover, MMP-3 is able to activate 
MMP-9  (Lagente  et  al.,  2005).  Normally,  the  active  MMP-9  is  bound  tightly  by  TIMP-1  which 
inactivates MMP-9. Nevertheless, the active MMP-3 might activate pro MMP-9 to become active MMP-9 
which next vulnerably degrade extracellular matrix of smoking-exposed tissues particularly lung and 
periodontium (Dahlen et al., 1999; Ziora et al., 2008). 
 
To date, biomarkers  have been developed  in order to assess  the severity of disease based  on 
cytokines, chemokines, oxidants and proteases. They were apparently helpful to evaluate 
pathophysiology, inflammation stages, destruction and lung remodeling in COPD. But, the availability 
of  opted  biomarkers  should  be  considered  by  using  minimally  invasive  procedures.  The  study 
suggested gingival crevicular fluid (GCF) and sputum as they were easily collected for assessing both 
MMP-3 and MMP-9 from lung and periodontium due to smoking (Snell N and Newbold, 2008; Cazzola 
M and Novelli, 2010). 
 
The study aimed to correlate the influence of active MMP-3 towards active MMP-9 from both GCF and 
sputum among emphysematous patients. 
 
Materials and Methods 
Procedure 
All The study methods and procedures were approved officially by the Ethical Committee of Faculty of 
Medicine, Syiah Kuala University, Banda Aceh-Indonesia. Fifteen outpatients at Pulmonary Policlinic of 
Zainoel Abidin Hospital, Banda Aceh-Indonesia were recruited as respondents. They were male, >50 
year olds, smokers or ex smokers, had 20 pack years and more. Those with asthmatic, infection of 
respiratory lower tract and pulmonary malignancies were excluded as respondents. 
 
Furthermore, all eligible respondents had to undergo the physical examination, spirometry test, and 
CT scan as well. And showed FEV1/FVC ratio <70%, FEV1% predicted <50%. Next, respondents 
underwent sputum induction by nebulizer-assisted 3% NaCl solution collected into sterile pots. Then, 
GCF was collected by putting a small piece of cut Whatman® filter paper (2 mm x 8 mm) into gingival 
sulci stored into micro-centrifuge tubes (Johnson et al., 1999). All samples were preserved into 800C 
freezer for further analysis. The activity of MMP-9 from both sputum and GCF was analyzed by using 
Sensolyte® 520 Generic MMP assay kit Fluorimetric. 
 
Results and Discussion 
Characteristics of Respondents and MMP-3, -9 Activities 
Respondents were patients suffering from emphysema who had means (SD) of age and FEV1/FVC ratio 
were 59.53 (5.579) years old and 44.65 (7.356) % respectively. Regarding MMP-3 activities, they 
were 1.36 (0.892) M and 1.70 (1.330) M from GCF and sputum respectively. Moreover, the MMP-9 
activities were 0.94 (0.722) M and 1.65 (1.574) M from GCF and sputum respectively. The data 
were as shown in Table 1. 
 
  Table 1. Characteristics of Respondents and MMP-3, -9 Activity   
                           Variables                                n                  Mean (SD)   
 
Age (yr) 15  59.53 (5.579) 
FEV1/FVC ratio (%) 15  44.65 (7.356) 
MMP-3 Activity of GCF (M) 15  1.36 (0,892) 
MMP-9 Activity of GCF (M) 15  0.94 (0.722) 
MMP-3 Activity of sputum (M) 15  1.70 (1.330) 
MMP-9 Activity of sputum (M) 15  1.65 (1.574) 
Correlations of MMP-3 Activity towards MMP-9 Activity 
 
The MMP-3 activities showed strong correlation towards MMP-9 activities from both GCF and sputum, 
i.e r=0.899 (table 2.) and r=0.770 (table.3) respectively. 
 
  Table 2. The Correlation of MMP-3 Activity towards MMP-9 Activity from GCF   
                           MMP-9 Activity 
 
 r p value 
MMP-3 Activity 0.899 <0.05 
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Table 3. The Correlation of MMP-3 Activity towards MMP-9 Activity from Sputum 
 
MMP-9 Activity 
 
r                                 p value 
 
 
MMP-3 Activity                               0.770                              <0.05 
 
 
Our study chose gingival crevicular fluid (GCF) and sputum for evaluating MMP-3 and MMP-9 as they 
were easily collected with simple procedure. Previous studies have assessed the level and activity of 
MMP-9 from various body fluids, e.g. bronchoalveolar  lavage  (BAL) and blood serum.  Increased 
activity of MMP-9 may cleave ECM of lung tissue. Normally, those suffering from COPD, having lower 
FEV1  and FEV1/FVC ratio <70, would also exhibit increased level and activity of MMP-3 and MMP-9. 
However, the study assessed activity of those proteases instead of level since activity assessment 
might represent the breakage of ECM. Activity has only measured active MMP-3 and MMP-9 cleaving 
substrates (Lowrey et al., 2008). 
 
The correlation of active MMP-3 towards active MMP-9 showed better correlation. Active MMP-3 is 
positively correlated with activity of MMP-9, i.e. r=0.899 (p<0.05) and r=0.770 (p<0.05) from GCF 
and sputum respectively. Regarding MMP-3, the fibroblast has stimulated pro inflammatory mediators, 
mainly TNF-α, to release pro MMP-3. The activation of MMP-3 might be done by cathepsin G and 
elastase. The active MMP-3 could activate pro MMP-9. Then, both active MMP-3 and MMP-9 could 
cleave ECM concurrently (Beklen et al., 2006). 
 
The imbalance of protease and anti protease normally increased among COPD respondents found in 
sputum. However, Correlation of MMP-9 activity is linear with the number of neutrophils from inflamed 
airways caused by prolonged exposure of smoking leading ECM degradation of lung parenchyma 
commonly known as emphysema. Moreover, airway obstruction commonly occurs in small airway and 
lung parenchyma evaluated with radiological examination and spirometry (Boschetto  et al., 20006; 
Chaudhuri et al., 2013). 
 
The lung responded more than the periodontal tissues in regards with the activities of MMP-3 and 
MMP-9  among  smokers  with  chronic  obstructive  pulmonary  disease  (COPD).  Smoking  exposure 
induced the raise of netrophils, macrophages, and other inflammatory mediators leading the release of 
MMP-3 and MMP-9. The excess of active MMP-3 and MMP-9 could degrade the extracellular matrix 
(ECM) of respective tissues, i.e. lung and periodontium. Besides ECM degradation, active MMP-3 was 
able to activate pro MMP-9. The active MMP-3 was related with increased expression of mRNA of MMP- 
3. Increased activity of MMP-3 was also influential with recovery process of injured tissues. The study 
has found the correlation of active MMP-3 and active MMP-9 with significantly strong correlation. 
Additionally, active MMP-3 could impair the balance between MMP-9 and TIMP-1 (Ziora et al., 2008; 
Kumar, et al., 2013). 
 
The  tide of MMP-9 activity  apparently  showed  dynamic  sequence  relying  on prolonged  smoking 
exposure which was supposed to be responsible upon MMP-9 activity (Boschetto et al., 2006). The 
active MMP-3 was supposedly involved in recruiting neutrophils  influx into the tissues so that it 
enabled more severity and mortality to take place inside the tissues. The active MMP-3 was also 
responsible in acute stage of inflammation. Together with MMP-9, the degradation of extracellular 
matrix of tissues might end result worse (Nerusu et al., 2007). Moreover, TIMP-1 also keeps arise to 
maintain  the  balance.  Increased  activity  of  MMP-9  corresponds  with  airway  obstruction  and 
destruction  of  extracellular  matrix  among  COPD  patients.  Moreover,  airway  obstruction  is  also 
together with increase of MMP-9/TIMP-1 ratio (Abdella et al., 2015). 
 
Conclusions 
The active of MMP-3 might be influential to activate MMP-9 from both GCF and sputum. Then, MMP-9 
could raise its activity and supposedly lead to ECM degradation. 
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